Intellectual Property UK

  • April 26, 2024

    Skechers Loses Bid To Register 'Just Slip In' TM

    American sneakers giant Skechers has lost its fight to win trademark protection for its "Just Slip In" slogan, with a European patent authority appeal board concluding that the phrase merely describes the shoes.

  • April 26, 2024

    Coca-Cola Chews Up Greek Rival's 'Tsakiris' Snack TM

    A Coca-Cola subsidiary defeated a rival that wanted to register the trademark "Tsakiris" to sell cereal snacks, after a European court ruled that it would take unfair advantage of the soft drink giant's reputation in Greek potato chips.

  • April 26, 2024

    Billboard Biz Gets OK To Fight To Opt Back Into UPC System

    Billboard advertising firm Aim Sport can have another chance to challenge a ruling by the Unified Patents Court, which held that its decision to opt out of Europe's umbrella patents court system is permanent and cannot be revoked, the UPC ruled Friday.

  • April 26, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen budget airline Ryanair file a claim against NATS PLC after the air traffic controller's system collapsed, Mastercard and Visa Europe face group claims from Christian Dior and dozens of other beauty retailers, an intellectual property clash between the publisher of The Sun and ITV, and ISC Europe sue a former director for alleged money laundering. Here, Law360 looks at these and other new claims in the U.K.

  • April 26, 2024

    Luxury Streetwear Brand Off-White Can't Block 'On White' TM

    Luxury streetwear brand Off White has failed to convince the U.K.'s intellectual property authority to block a toothpaste brand from registering its "On White" trademark, with the regulator finding that there was no likelihood that the public would confuse the two logos.

  • April 25, 2024

    Game Cheat Tools Don't Infringe Copyright, EU Advocate Says

    Third-party video game cheating software should not infringe game creators' copyright in the European Union if it only manipulates a gamer's input rather than the game's code itself, a legal adviser to the bloc's top court said Thursday amid Sony's dispute with a British gaming business.

  • April 25, 2024

    TM Applicants Must Prove Lost Reputation, EU Court Rules

    A European court said Wednesday that a trademark's reputation can be "progressively" lost over time, ruling that companies must prove another trademark's reputation has fully dwindled in order to register a similar mark in a dispute over an LVMH-owned perfume brand.

  • April 25, 2024

    Pharma R&D Biz Set To Exit London Market

    Pharmaceutical development specialist C4X Discovery Holdings PLC is set to delist from the London Stock Exchange on Friday, as it looks to go private to raise more funds amid concerns about the regulatory "burden" linked to its junior market.

  • April 25, 2024

    Jim Beam Loses TM Dispute Over 'Pinnacle' Name

    American distiller Jim Beam failed to block a trademark for "Pinnacle Gin" because a similarly branded vodka company it owns isn't on the market in the U.K.

  • April 25, 2024

    Wachtell Steers Perrigo In €275M Unit Sale To Pharma Biz

    Healthcare company Perrigo said Thursday that it has agreed to sell its pharmaceutical division for rare diseases to pharmaceutical company Esteve Healthcare SL for €275 million ($295 million) in a deal guided by Wachtell Lipton Rosen & Katz and Clifford Chance LLP.

  • April 25, 2024

    Zara's Reputation Not Enough To Block 'Zarzar' TM

    Zara's owner has lost its bid to stop a U.K. trademark for "Zarzar" after the U.K. Intellectual Property Office found that any link between the high-street fashion giant and a company offering modeling services would be "fleeting and tenuous."

  • April 25, 2024

    German Pharma Biz Blocks Italian Cosmetics TM

    A European court has overturned a decision that allowed Italian cosmetic dermatology brand Pherla Medical to register a trademark for its name, ruling that the logo was too similar to that of German pharmaceuticals company Verla-Pharm Arzneimittel.

  • April 25, 2024

    Hipgnosis Ditches Blackstone Bid For Concord's $1.5B Offer

    Hipgnosis Songs has accepted a revised offer from its U.S. competitor Concord Chorus to buy the music rights investor for $1.5 billion, ditching Blackstone's $1.2 billion offer just days after accepting the private equity giant's deal.

  • April 24, 2024

    Ex-Yukos Oil Shareholders To Auction Russian Vodka Brands

    The Benelux rights to trademarks for 18 Russian vodka brands, including Stolichnaya and Moskovskaya, will go to auction in June in the Netherlands, the former shareholders of Yukos Oil Co. said Wednesday as they sought to enforce arbitral awards now valued at $60 billion.

  • April 24, 2024

    Klarna Trims Down Basque Bank's European Logo TM

    Buy-now, pay-later giant Klarna has won its fight to restrict trademark registration for a Spanish bank's logo, blocking protection in a myriad of categories ranging from laundry detergent to musical instruments.

  • April 24, 2024

    EU Geographic IP Rules Promoting Sustainability To Launch In May

    New rules for geographical indications covering agricultural products, wines and spirit drinks in the European Union will kick in on May 13, part of the bloc's plan to boost uptake of the niche intellectual property right.

  • April 24, 2024

    Labcorp Prevails Over Software Biz TM Challenge In EU

    Labcorp has cleared its path to a trademark over its name in the European Union after a court ruled Wednesday that a German software business can't halt the application based on its earlier "labcore" signs that it has not sufficiently used in recent years.

  • April 24, 2024

    Panasonic Denies 'Illegitimate Pressure' In 4G Patent Fight

    Panasonic told a London court Wednesday that a bid by rival Xiaomi to have the Japanese giant's litigation accusing it of infringing standard essential wireless patents in other European courts thrown out is "dead in the water," saying its overseas claims against the company are legitimate.

  • April 24, 2024

    Monster Energy Can't Get Descriptive 'Flavor Unleashed' TM

    Monster Energy's "Flavor Unleashed" logo is not distinctive enough for a European Union trademark because it simply describes the characteristics of the drinks it appears on, an intellectual property appeals panel in the bloc said Wednesday.

  • April 24, 2024

    Marine Tech Co. Fights MoD Unit's 'Inflated' $90M Claim

    A South Korean marine navigation business that misused a Ministry of Defence agency's data to make its own products has hit back at the agency's claim for as much as $90 million, alleging it includes jacked-up figures and miscalculations.

  • April 24, 2024

    IP Firm Can't Take Bid To Block Clients' Case To Top Court

    Britain's highest court has rejected a final attempt by Marks & Clerk LLP to block thousands of former clients from bringing a bribery class action over alleged secret commission payments, ruling that the law firm did not put forward any arguable legal challenges that justified an appeal.

  • April 23, 2024

    Advertising Biz Can't Avoid Liability For Billboard Tech IP

    A London appeals court ruled Tuesday that a sports advertising company's digital billboard displays did not analyze pixels in a different enough way to overturn a finding that it infringed a rival's patent for the moving displays.

  • April 23, 2024

    Biotech Gets Rival's DNA-Detection Patents Invalidated

    A London court nixed two DNA sequence detection patents Tuesday, ruling that information available before they were protected would have prompted skilled scientists to make the invention eventually.

  • April 23, 2024

    Novartis Wins TM Fight After Trade Services Linked To Retail

    Altamedics has lost a bid to register a trademark for its name after European officials ruled that buyers would think its products came from Novartis, which had already registered the "Alta" brand for similar pharmaceutical goods.

  • April 23, 2024

    Panasonic Accused Of 'Illegitimate Pressure' In Patent Fight

    Chinese electronics giant Xiaomi asked a London court on Tuesday to prevent Panasonic from suing it in overseas jurisdictions amid a patent dispute, arguing that its Japanese rival is using the threat of injunctions to put pressure on it to accept a licensing deal.

Expert Analysis

  • EU Court Brings New Copyright Liability For Linked Material

    Author Photo

    The EU Court of Justice recently ruled that websites that merely link to infringing material can be liable for copyright infringement. If GS Media v. Sanoma stands, it threatens to disrupt common practices on a wide variety of websites and social media platforms, say Jennifer Stanley and Liwen Mah of Fenwick & West LLP.

  • Best Of Times And Worst Of Times For International IP

    Author Photo

    While the intellectual property environment is healthy, the international trade environment is not. The troubling situation raises the question of whether prevailing anti-trade sentiment will undercut IP harmonization progress and jeopardize the future of the global IP system, say Jay Erstling and Amy Salmela of Patterson Thuente Pedersen PA.

  • The Complicated Role Of Copyright In EU Pay-TV Case

    Author Photo

    While the European Commission's decision to close its antitrust investigation of Paramount Pictures does not mark the end of the pay-TV investigation, which continues against other studios and broadcasters, the history of the case and the terms of this settlement provide an interesting insight into the EC’s current views on the interaction between competition law and copyright, say Becket McGrath and Trupti Reddy of Cooley LLP.

  • Deciding Where To File Patents Internationally In 2016

    Author Photo

    Staying tethered to old patent filing strategies can soothe the cognitive dissonance created by a rapidly changing world. But applicants should resist the siren song of the old standbys to optimally adapt their patent portfolios to a world in economic and political flux, says Stephen Keefe, patent counsel at the Getinge Group.

  • What Brexit Means For EU Patents And Trademarks

    Author Photo

    Until the end of the negotiation period that will follow the Brexit vote, EU laws will continue to apply in the U.K., and intellectual property owners will likely experience no change in their rights in the U.K. until at least 2018, say Peter Pappas and Karissa Blyth of Sutherland Asbill & Brennan LLP.

  • 7 Reasons Revocation In EU Could Be As Popular As IPR In US

    Author Photo

    In addition to providing a forum for centralized enforcement of European patents, the Unified Patent Court will offer a new opportunity for challengers to invalidate a European patent centrally in a single action. There are some similarities between UPC revocation actions and the hugely successful inter partes reviews in the U.S., say Leythem Wall and Hazel Ford of Finnegan Henderson Farabow Garrett & Dunner LLP.

  • UK Supreme Court Clarifies Scope Of EU Design Protection

    Author Photo

    The U.K. Supreme Court's reasoning in a dispute involving children’s suitcase manufacturers raises important points for those filing community registered design right applications in Europe, says Dafydd Bevan of Marks & Clerk.

  • A New Dawn For European Patents

    Author Photo

    The creation of a new European Unified Patent Court and a new patent with unitary effect — expected to come into force next year — is the most important change in the European patent system since the European Patent Convention came into effect in October 1977. It will fundamentally change the international patent litigation landscape, say attorneys with Jones Day.

  • A Successful Follow-On Inter Partes Review Petition

    Author Photo

    The Patent Trial and Appeal Board's recent decision in World Bottling Cap shows that a second petition for inter partes review will be considered by the PTAB when the facts and additional prior art warrant, says Ted Baroody of Carstens & Cahoon LLP.

  • Get Ready For EU Unified Patent Court And Unitary Patent

    Author Photo

    Big change is coming to European patent litigation — as early as January 2017, a new single Unified Patent Court will commence operation. The time for U.S. companies with European patents to start planning and preparing is now, say Ron Lopez and Jennifer Hayes of Nixon Peabody LLP.

  • Effective IP Enforcement Is Taking Shape In China

    Author Photo

    As the Chinese economy grows and becomes more intertwined with other world economies, non-Chinese intellectual property rights holders in the energy sector must understand new enforcement mechanisms under the National Intellectual Property Rights Strategy Action Plan to maintain a competitive IP strategy, say Brad Chin and Kevin Tamm of Bracewell & Giuliani LLP.

  • Privacy, Security, Risk: What You Missed At IAPP Conference

    Author Photo

    A few weeks ago, privacy and security professionals from around the globe gathered for the second joint conference between the International Association of Privacy Professionals and the Cloud Security Alliance Congress. Aravind Swaminathan, Antony Kim and Emily Tabatabai of Orrick Herrington & Sutcliffe LLP offer seven key takeaways.

  • Approach To '2nd Medical Use' Claims Varies Across EU

    Author Photo

    A number of recent court decisions have highlighted important gaps and a lack of consensus between key EU member states on the law regarding infringement of second medical use patents. The rulings also demonstrate how differences in the drug dispensing and reimbursement systems between different EU countries can influence the nature of the relief available, say attorneys with Jones Day.

  • 5 Ways University Students, Faculty Risk Forfeiting IP Rights

    Author Photo

    Although academic institutions recognize the value of translating research into patents, licenses and commercial products, there remains a strong scholastic motivation for faculty and students to publish their research findings in journals and at academic conferences to advance their reputation and career. As a result, intellectual property is often an afterthought, say attorneys with Meunier Carlin & Curfman LLC.

  • EPO Set To Clarify Priority And Divisional Application Problem

    Author Photo

    In a recent decision, one European Patent Office Board of Appeal finally decided that the question of the possibility of poisonous priority and divisional applications should be settled once and for all. The Enlarged Board of Appeal may simply do away with poisonous applications or possibly formulate detailed criteria for the assessment of partial priority, say attorneys with CH KILGER Anwaltspartnerschaft mbB.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!